Senicapoc and Perampanel for Newly Diagnosed Glioblastoma

NCT07284069 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: senicapoc
DRUG: Perampanel

Sponsor

Aarhus University Hospital

Collaborators

[object Object]
[object Object]